Donor cell‐derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia | Zendy

Miller Kevin C. | Zendy; Abdel Rahman Zaid H. | Zendy; Robetorye Ryan S. | Zendy; Foran James M. | Zendy

Open Access

Donor cell‐derived chronic myelomonocytic leukemia presenting after allogeneic hematopoietic cell transplantation for T‐cell acute lymphoblastic leukemia

Author(s) -

Miller Kevin C.,

Abdel Rahman Zaid H.,

Robetorye Ryan S.,

Foran James M.

Publication year - 2020

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.3383

Subject(s) - medicine , chronic myelomonocytic leukemia , hematopoietic stem cell transplantation , transplantation , leukemia , hematopoietic cell , lymphoblastic leukemia , juvenile myelomonocytic leukemia , immunology , haematopoiesis , cancer research , stem cell , bone marrow , myelodysplastic syndromes , biology , genetics

Donor cell leukemia is a very rare cause of relapse after allogeneic hematopoietic cell transplantation (alloHCT). Herein, we describe an unprecedented case of donor cell‐derived chronic myelomonocytic leukemia (CMML) presenting seven years after a 51‐year‐old man received a matched‐related alloHCT from his 59‐year‐old brother for T‐cell acute lymphoblastic leukemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research